Informazioni su Zai Lab Limited - American Depositary Shares Panoramica della società da Wikipedia

Wikidata ↗

ZLAB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$25.29

Capitalizzazione di Mercato

$28.29B

P/E (TTM)

-159.8

EPS (TTM)

$-0.16

Ricavi (TTM)

$460M

Rendimento div.

—

ROE

-23.3%

D/E Debito/Patrimonio

0.3

Intervallo 52 sett.

$16 – $36

ZLAB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $460M

2018-12-31 → 2025-12-31

EPS $-0.16

2020-12-31 → 2025-12-31

Flusso di cassa libero $-159M

2020-12-31 → 2025-12-31

Margini -38.1%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

ZLAB

Mediana dei peer

P/E (TTM)

-159.8

21.9

P/S (TTM)

61.5

14.1

P/B

39.5

3.9

EV / EBITDA

-129.7

—

Price / FCF (Prezzo / FCF)

-178.0

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

ZLAB

Mediana dei peer

Operating Margin (Margine Operativo)

-49.9%

—

Net Profit Margin (Margine di Profitto Netto)

-38.1%

-36.0%

ROA

-14.9%

-20.8%

ROE

-23.3%

-29.7%

ROIC

-24.5%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

ZLAB

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.3

3.9

Current Ratio (Rapporto corrente)

2.4

5.8

Quick Ratio

1.9

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

ZLAB

Mediana dei peer

Revenue YoY (Ricavi YoY)

15.3%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

28.9%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

56.5%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

ZLAB

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-0.16

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

ZLAB

Mediana dei peer

ZLAB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 14 analisti

Acquisto forte 2 14,3%
Compra 9 64,3%
Mantieni 3 21,4%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

12 analisti · 2026-08-18

Mediana $28.27

Media $32.18

Ora $25.29

Basso $24.25

Alto $50.00

Target mediano $28.27 +11,8%

Target medio $32.18 +27,3%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.01%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.05	$-0.07	0.02%
31 Marzo 2026	$-0.05	$-0.05	-0.00%
31 Dicembre 2025	$-0.05	$-0.07	0.02%
30 Settembre 2025	$-0.03	$-0.04	0.01%
30 Giugno 2025	$-0.04	$-0.04	0.00%
31 Marzo 2025	$-0.05	$-0.07	0.02%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue	$460M	$399M	$267M	$215M	$144M	$49M	$13M
Cost of Revenue	$191M	$147M	$96M	$74M	$52M	$17M	$4M
R&D Expense	$221M	$235M	$266M	$286M	$573M	$223M	$142M
SG&A Expense	$278M	$299M	$282M	$259M	$219M	$111M	$70M
Operating Income	$-229M	$-282M	$-367M	$-404M	$-700M	$-302M	$-203M
Interest Expense	·	$2M	$0	$0	$0	$181.0K	$293.0K
Interest Income	$33M	$37M	$40M	$15M	$2M	$5M	$8M
Other Non-op	$4M	$5M	$7M	$3M	$-10M	$7M	$938.0K
Pretax Income	$-178M	$-257M	$-335M	$-443M	$-704M	$-269M	$-194M
Income Tax	$-3M	$0	$0	$0	$0	$0	·
Net Income	$-176M	$-257M	$-335M	$-443M	$-704M	$-269M	$-195M
EPS (Basic)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·
EPS (Diluted)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·
Shares (Basic)	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·
Shares (Diluted)	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·
EBITDA	$-214M	$-270M	$-358M	·	$-694M	$-297M	·

Stato Patrimoniale 26

Dati annuali Stato Patrimoniale per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$680M	$450M	$790M	$1.01B	$964M	$442M	$76M
Short-term Investments	$10M	$330M	$16M	$0	$445M	$745M	$200M
Receivables	$106M	$85M	$59M	$40M	$47M	$5M	$4M
Inventory	$75M	$40M	$45M	$32M	$19M	$13M	$6M
Prepaid Expense	$37M	$42M	$23M	$36M	$18M	$11M	$7M
Current Assets	$1.02B	$1.05B	$940M	$1.12B	$1.50B	$1.22B	$292M
PP&E (Net)	$47M	$48M	$54M	$58M	$43M	$29M	$21M
PP&E (Gross)	$90M	$85M	$84M	$80M	$60M	$39M	$27M
Accum. Depreciation	$42M	$37M	$30M	$22M	$16M	$10M	$5M
Intangibles	$76M	$56M	$13M	$2M	$2M	$2M	$1M
Other Non-current Assets	$3M	$6M	·	·	·	·	·
Total Assets	$1.17B	$1.19B	$1.04B	$1.22B	$1.61B	$1.30B	$355M
Accounts Payable	$142M	$101M	$113M	$66M	$126M	$63M	$23M
Short-term Debt	$205M	$132M	$0	·	·	·	$6M
Current Liabilities	$416M	$299M	$203M	$140M	$193M	$98M	$47M
Capital Leases	$13M	$14M	$8M	$13M	$10M	$13M	$11M
Other Non-current Liabilities	$0	$325.0K	$325.0K	$0	·	·	·
Total Liabilities	$457M	$345M	$240M	$175M	$230M	$128M	$60M
Total Debt	$205M	$132M	·	·	·	·	·
Common Stock	$7.0K	$7.0K	$6.0K	$6.0K	$6.0K	$5.0K	$4.0K
Retained Earnings	$-2.63B	$-2.45B	$-2.20B	$-1.86B	$-1.42B	$-714M	$-445M
Treasury Stock	$29M	$21M	$21M	$12M	$4M	$0	·
AOCI	$30M	$51M	$38M	$26M	$-24M	$-15M	$5M
Stockholders' Equity	$716M	$841M	$796M	$1.05B	$1.38B	$1.17B	$295M
Liabilities + Equity	$1.17B	$1.19B	$1.04B	$1.22B	$1.61B	$1.30B	$355M
Shares Outstanding	1,106,389,340	1,082,614,740	977,151,270	962,455,850	955,363,980	878,110,260	682,372,470

Flusso di cassa 13

Dati annuali Flusso di cassa per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
D&A	$15M	$12M	$9M	$8M	$6M	$5M	$4M
Stock-based Comp	$66M	$71M	$80M	$61M	$41M	$25M	$20M
Amort. of Intangibles	$6M	$3M	$700.0K	$500.0K	$500.0K	$300.0K	$305.0K
Other Non-cash	$-56M	$-40M	$48M	·	$108M	$23M	·
Operating Cash Flow	$-151M	$-215M	$-198M	$-368M	$-549M	$-216M	$-191M
CapEx	$8M	$6M	$7M	$25M	$18M	$10M	$6M
Investing Cash Flow	$308M	$-375M	$-11M	$420M	$250M	$-555M	$-15M
Stock Issued	$0	$217M	$0	$0	·	·	·
Net Stock Activity	$0	$217M	·	·	·	·	·
Financing Cash Flow	$72M	$350M	$-6M	$-2M	$820M	$1.13B	$219M
Net Change in Cash	$230M	$-240M	$-218M	$44M	$522M	$366M	$13M
Free Cash Flow	$-159M	$-221M	$-205M	·	$-568M	$-226M	·
Levered FCF	·	$-223M	·	·	·	·	·

Redditività 7

Dati annuali Redditività per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-49.9%	-70.7%	-137.4%	·	-485.1%	-616.5%	·
Net Margin	-38.1%	-64.4%	-125.5%	·	-488.2%	-549.3%	·
Pretax Margin	-38.8%	-64.4%	-125.5%	·	-487.4%	-549.3%	·
EBITDA Margin	-46.6%	-67.7%	-134.1%	·	-480.6%	-607.0%	·
ROA	-14.9%	-23.1%	-29.7%	·	-48.5%	-32.5%	·
ROE	-23.3%	-34.1%	-39.9%	·	-47.5%	-23.3%	·
ROIC	-24.5%	-29.0%	-46.1%	·	·	·	·

Liquidità e Solvibilità 4

Dati annuali Liquidità e Solvibilità per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Current Ratio	2.4	3.5	4.6	·	7.8	12.4	·
Quick Ratio	1.9	2.9	4.3	·	7.6	12.2	·
Debt / Equity	0.3	0.2	·	·	·	·	·
Interest Coverage	·	-125.2	·	·	·	-1667.4	·

Efficienza 3

Dati annuali Efficienza per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.4	0.4	0.2	·	0.1	0.1	·
Inventory Turnover	3.3	3.5	2.5	·	3.3	1.7	·
Receivables Turnover	4.8	5.5	5.4	·	5.5	10.9	·

Per Azione 5

Dati annuali Per Azione per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$0.65	$0.78	$0.82	·	$14.44	$13.32	·
Revenue / Share	$0.42	$0.40	$0.28	·	·	·	·
Cash Flow / Share	$-0.14	$-0.22	$-0.21	·	·	·	·
Cash / Share	$0.61	$0.42	$0.81	·	$10.09	$5.03	·
EPS (TTM)	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76	$-0.35	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	15.3%	49.6%	24.0%	49.0%	194.8%	·	·
Revenue CAGR 3Y	28.9%	40.4%	76.0%	·	·	·	·
Revenue CAGR 5Y	56.5%	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per ZLAB
Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$460M	$399M	$267M	$215M	$144M	$49M	·
Net Income TTM	$-176M	$-257M	$-335M	$-443M	$-704M	$-269M	·
Market Cap	$19.52B	$28.23B	$26.57B	·	$6.00B	$11.88B	·
Enterprise Value	$19.03B	$27.58B	·	·	·	·	·
P/E	-110.2	-100.7	-78.1	-66.7	-82.7	-386.7	·
P/S	42.4	70.7	99.6	·	41.6	242.7	·
P/B	27.3	33.6	33.4	·	4.4	10.2	·
P / Tangible Book	30.5	36.0	33.9	28.2	4.4	10.2	·
P / Cash Flow	-129.4	-131.4	-134.1	·	-10.9	-55.0	·
P / FCF	-122.8	-128.0	-129.4	·	-10.6	-52.5	·
EV / EBITDA	-88.8	-102.0	·	·	·	·	·
EV / FCF	-119.8	-125.1	·	·	·	·	·
EV / Revenue	41.4	69.1	·	·	·	·	·
Earnings Yield	-0.91%	-0.99%	-1.3%	-1.5%	-1.2%	-0.26%	·

Conto Economico 16

Dati trimestrali Conto Economico per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$106M	$100M	$128M	$116M	$110M	$106M	$109M	$102M	$101M	$87M	$66M	$69M	$69M	$63M	$63M	$58M
Cost of Revenue	$48M	$38M	$62M	$47M	$43M	$38M	$42M	$37M	$35M	$34M	$25M	$25M	$24M	$21M	$21M	$20M
R&D Expense	$62M	$66M	$62M	$48M	$51M	$61M	$52M	$66M	$62M	$55M	$82M	$59M	$77M	$48M	$67M	$100M
SG&A Expense	$73M	$65M	$73M	$70M	$71M	$63M	$83M	$67M	$80M	$69M	$83M	$69M	$68M	$63M	$72M	$67M
Operating Income	$-76M	$-69M	$-69M	$-49M	$-55M	$-56M	$-68M	$-68M	$-76M	$-70M	$-124M	$-84M	$-90M	$-70M	$-97M	$-129M
Interest Expense	·	·	·	·	·	·	·	·	·	$113.0K	·	·	·	$0	·	·
Interest Income	$6M	$6M	$7M	$8M	$9M	$9M	$9M	$9M	$9M	$10M	$10M	$9M	$10M	$10M	$9M	$4M
Other Non-op	$5M	$162.0K	$495.0K	$-508.0K	$4M	$-197.0K	$1M	$3M	$-9M	$9M	$7M	$394.0K	$-1M	$1M	$10M	$4M
Pretax Income	$-52M	$-50M	$-53M	$-36M	$-41M	$-48M	$-82M	$-42M	$-80M	$-53M	$-95M	$-69M	$-121M	$-49M	$-62M	$-161M
Income Tax	$-1M	$1M	$-3M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$-51M	$-51M	$-50M	$-36M	$-41M	$-48M	$-82M	$-42M	$-80M	$-53M	$-95M	$-69M	$-121M	$-49M	$-62M	$-161M
EPS (Basic)	$-0.05	$-0.05	$-0.05	$-0.03	$-0.04	$-0.04	$-0.09	$-0.04	$-0.08	$-0.05	$-0.10	$-0.07	$-0.13	$-0.05	$-0.06	$-0.17
EPS (Diluted)	$-0.05	$-0.05	$-0.05	$-0.03	$-0.04	$-0.04	$-0.09	$-0.04	$-0.08	$-0.05	$-0.10	$-0.07	$-0.13	$-0.05	$-0.06	$-0.17
Shares (Basic)	1,116,973,380	1,107,390,590	-2,179,520,040	1,102,072,680	1,091,933,150	1,080,825,300	-1,941,293,210	981,687,390	975,937,790	973,145,760	-1,928,635,690	968,767,730	964,817,310	961,444,780	-1,914,202,670	959,085,960
Shares (Diluted)	1,116,973,380	1,107,390,590	-2,179,520,040	1,102,072,680	1,091,933,150	1,080,825,300	-1,941,293,210	981,687,390	975,937,790	973,145,760	-1,928,635,690	968,767,730	964,817,310	961,444,780	-1,914,202,670	959,085,960
EBITDA	$-76M	$-65M	·	$-49M	$-55M	$-53M	·	$-68M	$-76M	$-67M	·	$-84M	$-90M	$-67M	·	$-129M

Stato Patrimoniale 26

Dati trimestrali Stato Patrimoniale per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$608M	$651M	$680M	$717M	$732M	$757M	$450M	$616M	$630M	$651M	·	$789M	$859M	$880M	·	$1.12B
Short-term Investments	$10M	$10M	$10M	$0	$0	$0	$330M	$0	$0	$0	·	$32M	$16M	$51M	·	$0
Receivables	$70M	$54M	$106M	$85M	$88M	$77M	$85M	$50M	$70M	$60M	·	$42M	$47M	$43M	·	$28M
Inventory	$91M	$86M	$75M	$67M	$62M	$53M	$40M	$40M	$42M	$38M	·	$44M	$36M	$38M	·	$29M
Prepaid Expense	$33M	$35M	$37M	$44M	$41M	$44M	$42M	$36M	$20M	$24M	·	$30M	$38M	$43M	·	$22M
Current Assets	$914M	$945M	$1.02B	$1.03B	$1.03B	$1.04B	$1.05B	$861M	$870M	$889M	·	$960M	$1.02B	$1.07B	·	$1.21B
PP&E (Net)	$46M	$47M	$47M	$49M	$50M	$50M	$48M	$51M	$51M	$52M	·	$55M	$56M	$58M	·	$51M
PP&E (Gross)	$94M	$92M	$90M	$89M	$89M	$89M	$85M	$87M	$85M	$85M	·	$83M	$82M	$83M	·	$71M
Accum. Depreciation	$47M	$45M	$42M	$41M	$39M	$39M	$37M	$36M	$34M	$32M	·	$28M	$26M	$24M	·	$20M
Intangibles	$86M	$76M	$76M	$55M	$57M	$56M	$56M	$52M	$44M	$12M	·	$2M	$2M	$1M	·	$2M
Other Non-current Assets	$4M	$3M	$3M	$2M	$3M	$3M	$6M	·	·	·	·	·	·	·	·	·
Total Assets	$1.07B	$1.10B	$1.17B	$1.16B	$1.16B	$1.17B	$1.19B	$985M	$987M	$988M	·	$1.04B	$1.11B	$1.17B	·	$1.30B
Accounts Payable	$137M	$126M	$142M	$100M	$107M	$103M	$101M	$121M	$127M	$88M	·	$55M	$67M	$66M	·	$90M
Short-term Debt	$238M	$214M	$205M	$203M	$175M	$173M	$132M	$113M	$70M	$48M	·	·	·	·	·	·
Current Liabilities	$429M	$393M	$416M	$360M	$332M	$320M	$299M	$286M	$252M	$192M	·	$125M	$133M	$125M	·	$156M
Capital Leases	$11M	$12M	$13M	$11M	$11M	$12M	$14M	$6M	$6M	$8M	·	$10M	$12M	$13M	·	$14M
Other Non-current Liabilities	$225.0K	$40.0K	$0	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	$325.0K	·	$325.0K	$325.0K	$325.0K	·	·
Total Liabilities	$468M	$434M	$457M	$399M	$372M	$363M	$345M	$318M	$283M	$226M	·	$163M	$174M	$169M	·	$193M
Total Debt	$238M	$214M	·	$203M	$175M	$173M	·	$113M	$70M	$48M	·	·	·	·	·	·
Common Stock	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$6.0K	$6.0K	·	$6.0K	$6.0K	$6.0K	·	$6.0K
Retained Earnings	$-2.73B	$-2.68B	$-2.63B	$-2.58B	$-2.54B	$-2.50B	$-2.45B	$-2.37B	$-2.33B	$-2.25B	·	$-2.10B	$-2.03B	$-1.91B	·	$-1.80B
Treasury Stock	$34M	$31M	$29M	$29M	$21M	$21M	$21M	$21M	$21M	$21M	·	$21M	$21M	$17M	·	$11M
AOCI	$214.0K	$15M	$30M	$40M	$46M	$49M	$51M	$28M	$43M	$39M	·	$48M	$52M	$17M	·	$40M
Stockholders' Equity	$607M	$662M	$716M	$760M	$792M	$811M	$841M	$668M	$704M	$762M	$796M	$881M	$932M	$1.00B	$1.05B	$1.11B
Liabilities + Equity	$1.07B	$1.10B	$1.17B	$1.16B	$1.16B	$1.17B	$1.19B	$985M	$987M	$988M	·	$1.04B	$1.11B	$1.17B	·	$1.30B
Shares Outstanding	1,122,445,390	1,110,232,620	1,106,389,340	1,105,865,950	1,099,112,890	1,084,164,200	1,077,702,540	984,356,170	981,398,140	973,285,510	977,151,270	969,037,150	968,566,280	963,688,740	962,455,850	959,724,940

Flusso di cassa 11

Dati trimestrali Flusso di cassa per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$2M	$2M
Stock-based Comp	$12M	$14M	$16M	$17M	$17M	$16M	$17M	$17M	$19M	$18M	$20M	$22M	$21M	$17M	$16M	$19M
Amort. of Intangibles	$2M	$2M	$1M	$2M	$2M	$2M	$1M	$700.0K	$800.0K	$700.0K	$200.0K	$200.0K	·	·	·	·
Other Non-cash	·	$22M	·	·	·	$-33M	·	·	·	$-58M	·	·	·	$-39M	·	·
Operating Cash Flow	$-63M	$-12M	$-26M	$-32M	$-31M	$-62M	$-56M	$-27M	$-42M	$-90M	$-15M	$-55M	$-59M	$-69M	$-109M	$-126M
CapEx	$1M	$1M	$677.0K	$3M	$3M	$2M	$3M	$1M	$741.0K	$974.0K	$222.0K	$2M	$2M	$4M	$4M	$7M
Investing Cash Flow	$-1M	$-22M	$-11M	$-4M	$-3M	$326M	$-348M	$-30M	$-846.0K	$3M	$14M	$-14M	$43M	$-54M	$-4M	$568M
Financing Cash Flow	$19M	$6M	$-430.0K	$21M	$9M	$43M	$238M	$42M	$22M	$48M	$393.0K	$-1M	$-1M	$-4M	$-199.0K	$709.0K
Net Change in Cash	$-44M	$-28M	$-38M	$-15M	$-25M	$308M	$-166M	$-14M	$-21M	$-39M	$666.0K	$-70M	$-20M	$-128M	$-111M	$439M
Free Cash Flow	·	$-13M	·	·	·	$-63M	·	·	·	$-91M	·	·	·	$-73M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-91M	·	·	·	·	·	·

Redditività 7

Dati trimestrali Redditività per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-72.0%	-69.7%	·	-42.0%	-49.9%	-52.9%	·	-66.3%	-75.7%	-80.7%	·	-120.7%	-130.0%	-110.7%	·	-223.5%
Net Margin	-47.8%	-51.2%	·	-31.0%	-37.0%	-45.5%	·	-40.8%	-79.9%	-61.4%	·	-99.9%	-175.6%	-78.3%	·	-280.1%
Pretax Margin	-48.8%	-49.8%	·	-31.0%	-37.0%	-45.5%	·	-40.8%	-79.9%	-61.4%	·	-99.9%	-175.6%	-78.3%	·	-280.1%
EBITDA Margin	-72.0%	-65.7%	·	-42.0%	-49.9%	-49.6%	·	-66.3%	-75.7%	-77.2%	·	-120.7%	-130.0%	-106.5%	·	-223.5%
ROA	-4.5%	-4.5%	·	-3.4%	-3.8%	-4.5%	·	-4.1%	-7.7%	-5.0%	·	-5.9%	-9.6%	-3.7%	·	-10.7%
ROE	-7.3%	-6.9%	·	-5.0%	-5.5%	-6.2%	·	-5.4%	-9.8%	-6.1%	·	-7.0%	-11.3%	-4.3%	·	-12.0%
ROIC	-8.9%	-8.2%	·	-5.1%	-5.7%	-5.7%	·	-8.7%	-9.8%	-8.7%	·	-9.5%	-9.6%	-6.9%	·	-11.6%

Liquidità e Solvibilità 4

Dati trimestrali Liquidità e Solvibilità per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	2.1	2.4	·	2.9	3.1	3.3	·	3.0	3.5	4.6	·	7.7	7.6	8.6	·	7.8
Quick Ratio	1.6	1.8	·	2.2	2.5	2.6	·	2.3	2.8	3.7	·	6.9	6.9	7.8	·	7.4
Debt / Equity	0.4	0.3	·	0.3	0.2	0.2	·	0.2	0.1	0.1	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-622.2	·	·	·	·	·	·

Efficienza 3

Dati trimestrali Efficienza per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.0	·	0.0
Inventory Turnover	0.6	0.6	·	0.9	0.8	0.8	·	0.9	0.9	0.9	·	0.7	0.8	0.7	·	1.0
Receivables Turnover	1.3	1.5	·	1.7	1.4	1.6	·	2.2	1.7	1.7	·	2.0	1.9	1.6	·	2.4

Per Azione 5

Dati trimestrali Per Azione per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.54	$0.60	·	$0.69	$0.72	$0.75	·	$0.68	$0.72	$0.78	·	$0.91	$0.96	$1.04	·	$1.15
Revenue / Share	$0.10	$0.09	·	$0.11	$0.10	$0.10	·	$0.10	$0.10	$0.09	·	$0.07	$0.07	$0.07	·	$0.06
Cash Flow / Share	·	$-0.01	·	·	·	$-0.06	·	·	·	$-0.09	·	·	·	$-0.07	·	·
Cash / Share	$0.54	$0.59	·	$0.65	$0.67	$0.70	·	$0.63	$0.64	$0.67	·	$0.81	$0.89	$0.91	·	$1.17
EPS (TTM)	$-0.17	$-0.16	·	$-0.15	$-0.20	$-0.21	·	$-0.24	$-0.33	$-0.30	·	$-0.42	$-0.49	$-0.45	·	$-0.50

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per ZLAB
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$432M	$432M	·	$435M	$419M	$396M	·	$359M	$326M	$288M	·	$258M	$237M	$215M	·	$196M
Net Income TTM	$-179M	$-176M	·	$-167M	$-211M	$-224M	·	$-245M	$-324M	$-293M	·	$-400M	$-469M	$-431M	·	$-593M
Market Cap	$21.33B	$20.88B	·	$37.48B	$38.44B	$39.18B	·	$23.76B	$17.01B	$15.59B	·	$23.56B	$26.86B	$32.05B	·	$32.82B
Enterprise Value	$20.95B	$20.44B	·	$36.96B	$37.88B	$38.60B	·	$23.26B	$16.45B	$14.99B	·	·	·	·	·	·
P/E	-111.8	-117.6	·	-225.9	-174.8	-172.1	·	-100.6	-52.5	-53.4	·	-57.9	-56.6	-73.9	·	-68.4
P/S	49.4	48.3	·	86.2	91.7	98.8	·	66.2	52.2	54.1	·	91.2	113.1	148.9	·	167.9
P/B	35.1	31.5	·	49.3	48.5	48.3	·	35.6	24.2	20.5	·	26.7	28.8	32.0	·	29.7
P / Tangible Book	40.9	35.6	·	53.2	52.3	51.9	·	38.6	25.8	20.8	·	26.8	28.9	32.1	·	29.7
P / Cash Flow	·	-1753.1	·	·	·	-635.0	·	·	·	-173.0	·	·	·	-462.6	·	·
P / FCF	·	-1593.3	·	·	·	-619.6	·	·	·	-171.2	·	·	·	-440.3	·	·
EV / EBITDA	-273.9	-312.3	·	-757.1	-690.0	-730.3	·	-342.8	-216.2	-222.7	·	·	·	·	·	·
EV / FCF	·	-1559.2	·	·	·	-610.4	·	·	·	-164.6	·	·	·	·	·	·
EV / Revenue	48.5	47.3	·	85.0	90.4	97.4	·	64.8	50.5	52.0	·	·	·	·	·	·
Earnings Yield	-0.89%	-0.85%	·	-0.44%	-0.57%	-0.58%	·	-0.99%	-1.9%	-1.9%	·	-1.7%	-1.8%	-1.4%	·	-1.5%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$460M	$399M	$267M	$215M	$144M
Margine Operativo %	-49.9%	-70.7%	-137.4%	—	-485.1%
Utile netto	$-176M	$-257M	$-335M	$-443M	$-704M
EPS Diluito	$-0.16	$-0.26	$-0.35	$-0.46	$-0.76

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.3	0.2	—	—	—
Rapporto corrente	2.4	3.5	4.6	—	7.8
Quick Ratio	1.9	2.9	4.3	—	7.6

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-159M	$-221M	$-205M	—	$-568M

Ultime notizie Notizie recenti che menzionano questa società

Zai Lab (ZLAB), Amgen (AMGN) collaborano per valutare la terapia combinata per il cancro ai polmoni Yahoo Finance · 3 mesi, 4 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 99 filer · $767.0M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
18 (-2 vs trimestre precedente)	21 (-20 vs trimestre precedente)	31 (+5 vs trimestre precedente)	22 (-16 vs trimestre precedente)	+14.6M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
RTW INVESTMENTS, LP	$124.906.608	6.574.032	16,29%	Azioni
TCG Crossover Management, LLC	$116.614.913	6.137.627	15,20%	Azioni
RA CAPITAL MANAGEMENT, L.P.	$109.127.127	5.743.533	14,23%	Azioni
ADAR1 Capital Management, LLC	$64.011.646	3.369.034	8,35%	Azioni
GOLDMAN SACHS GROUP INC	$43.994.120	2.315.480	5,74%	Azioni
Woodline Partners LP	$41.938.567	2.207.293	5,47%	Azioni
Frazier Life Sciences Management, L.P.	$36.144.080	1.902.320	4,71%	Azioni
BAMCO INC /NY/	$30.850.186	1.623.694	4,02%	Azioni
TWO SIGMA INVESTMENTS, LP	$24.688.486	1.299.394	3,22%	Azioni
CITADEL ADVISORS LLC	$24.409.414	1.284.706	3,18%	Azioni
FMR LLC	$20.659.061	1.087.319	2,69%	Azioni
Rock Springs Capital Management LP	$15.479.433	814.707	2,02%	Azioni
BlackRock, Inc.	$12.163.002	640.158	1,59%	Azioni
B Group, Inc.	$8.562.274	450.646	1,12%	Azioni
SCHRODER INVESTMENT MANAGEMENT GROUP	$7.238.204	393.167	0,94%	Azioni
NAN FUNG TRINITY (HK) LTD	$6.582.854	346.466	0,86%	Azioni
Aberdeen Group plc	$5.914.586	311.294	0,77%	Azioni
CITIGROUP INC	$5.714.706	300.774	0,75%	Azioni
Spruce Street Capital LP	$5.303.090	279.110	0,69%	Azioni
AMERIPRISE FINANCIAL INC	$4.808.539	253.081	0,63%	Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$4.692.658	246.982	0,61%	Azioni
Hudson Bay Capital Management LP	$4.085.000	215.000	0,53%	Azioni
JANE STREET GROUP, LLC	$3.864.600	203.400	0,50%	Opzione Put
Nantahala Capital Management, LLC	$3.800.000	200.000	0,50%	Azioni
NEXTBio Capital Management LP	$3.483.878	183.362	0,45%	Azioni
SUPERSTRING CAPITAL MANAGEMENT LP	$2.960.447	155.813	0,39%	Azioni
JANE STREET GROUP, LLC	$2.934.702	154.458	0,38%	Azioni
Seven Fleet Capital Management LP	$2.924.756	136.016	0,38%	Azioni
D. E. Shaw & Co., Inc.	$2.682.002	141.158	0,35%	Azioni
Privium Fund Management B.V.	$2.321.591	122.189	0,30%	Azioni
STATE STREET CORP	$2.296.074	120.846	0,30%	Azioni
AXA Investment Managers S.A.	$2.230.436	65.814	0,29%	Azioni
ALPS ADVISORS INC	$2.098.189	110.431	0,27%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.086.200	109.800	0,27%	Opzione Put
DIMENSIONAL FUND ADVISORS LP	$1.783.454	93.866	0,23%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.454.735	76.565	0,19%	Azioni
Orion Portfolio Solutions, LLC	$1.310.400	36.259	0,17%	Azioni
Virtus Investment Advisers, LLC	$1.294.356	68.124	0,17%	Azioni
Headlands Technologies LLC	$1.292.190	68.010	0,17%	Azioni
DCF Advisers, LLC	$1.206.500	63.500	0,16%	Azioni
CITADEL ADVISORS LLC	$953.800	50.200	0,12%	Opzione Put
Quadrature Capital Ltd	$741.532	39.028	0,10%	Azioni
WOLVERINE TRADING, LLC	$714.581	21.700	0,09%	Opzione Put
WealthPlan Investment Management, LLC	$698.459	36.761	0,09%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$453.701	23.879	0,06%	Azioni
NJ State Employees Deferred Compensation Plan	$382.957	11.300	0,05%	Azioni
XTX Topco Ltd	$348.631	18.349	0,05%	Azioni
Schonfeld Strategic Advisors LLC	$294.424	15.496	0,04%	Azioni
Squarepoint Ops LLC	$291.004	15.316	0,04%	Azioni
Erste Asset Management GmbH	$277.991	15.100	0,04%	Azioni
H D Vest Advisory Services	$275.494	7.878	0,04%	Azioni
NORTHERN TRUST CORP	$213.959	11.261	0,03%	Azioni
Vanguard Personalized Indexing Management, LLC	$211.489	11.131	0,03%	Azioni
Persistent Asset Partners Ltd	$209.760	11.040	0,03%	Azioni
TWO SIGMA SECURITIES, LLC	$192.546	10.134	0,03%	Azioni
JPMORGAN CHASE & CO	$122.592	6.659	0,02%	Azioni
China Universal Asset Management Co., Ltd.	$99.560	5.240	0,01%	Azioni
GROUP ONE TRADING LLC	$96.729	5.091	0,01%	Azioni
UBS Group AG	$80.275	4.225	0,01%	Azioni
Mirae Asset Global Investments Co., Ltd.	$74.594	3.926	0,01%	Azioni
SIMPLEX TRADING, LLC	$50.483	2.657	0,01%	Azioni
Legal & General Group Plc	$40.975	2.156	0,01%	Azioni
MARSHALL WACE, LLP	$32.262	1.698	0,00%	Azioni
MORGAN STANLEY	$27.645	1.455	0,00%	Azioni
Tower Research Capital LLC (TRC)	$19.190	1.010	0,00%	Azioni
US BANCORP \DE\	$17.024	896	0,00%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$14.592	768	0,00%	Azioni
GF FUND MANAGEMENT CO. LTD.	$13.851	729	0,00%	Azioni
Farther Finance Advisors, LLC	$13.064	690	0,00%	Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$11.813	628	0,00%	Azioni
C WorldWide Group Holding A/S	$9.690	510.000	0,00%	Azioni
MERCER GLOBAL ADVISORS INC /ADV	$8.949	471	0,00%	Azioni
Federation des caisses Desjardins du Quebec	$5.700	300	0,00%	Azioni
BARCLAYS PLC	$5.548	292	0,00%	Azioni
CWM, LLC	$5.436	289	0,00%	Azioni
ROYAL BANK OF CANADA	$4.000	222	0,00%	Azioni
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	$3.895	205	0,00%	Azioni
Arax Advisory Partners	$3.819	201	0,00%	Azioni
ASSETMARK, INC	$2.945	155	0,00%	Azioni
Quent Capital, LLC	$2.850	150	0,00%	Azioni
DEUTSCHE BANK AG\	$2.793	147	0,00%	Azioni
Smartleaf Asset Management LLC	$2.430	132	0,00%	Azioni
North Star Investment Management Corp.	$1.843	97	0,00%	Azioni
Ameritas Advisory Services, LLC	$1.444	76	0,00%	Azioni
EverSource Wealth Advisors, LLC	$1.368	72	0,00%	Azioni
AMERIFLEX GROUP, INC.	$1.178	62	0,00%	Azioni
WELLS FARGO & COMPANY/MN	$1.140	60	0,00%	Azioni
Invesco Ltd.	$779	41	0,00%	Azioni
OSAIC HOLDINGS, INC.	$760	40	0,00%	Azioni
SBI Securities Co., Ltd.	$760	40	0,00%	Azioni
Cornerstone Financial Management LLC	$608	32	0,00%	Azioni
Caitong International Asset Management Co., Ltd	$494	26	0,00%	Azioni
Bell Investment Advisors, Inc	$494	26	0,00%	Azioni
PNC Financial Services Group, Inc.	$494	26	0,00%	Azioni
Stone House Investment Management, LLC	$418	22	0,00%	Azioni
Blue Trust, Inc.	$95	5	0,00%	Azioni
Larson Financial Group LLC	$76	4	0,00%	Azioni
Integrated Wealth Concepts LLC	$57	3	0,00%	Azioni
BESSEMER GROUP INC	$1	60	0,00%	Azioni

Insider aziendali 20 insider · 11 dirigenti · 10 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Ying Du	Chairperson & CEO	02 Luglio 2026 A	1.221.401	0	15	$-8.578.643
Yajing Chen	Chief Financial Officer	14 Agosto 2026 M	35.895	0	7	$-232.240
William Ki Chul Cho	Chief Financial Officer	03 Aprile 2023 M	53.747	0	0	$0
Joshua L Smiley	President and Chief Operating Officer	06 Aprile 2026 S	117.602	1	4	$-245.924
Rafael Amado	President, Head of Global Oncology Research and Development	06 Aprile 2026 S	57.022	0	5	$-674.984
Harald Reinhart	President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases	25 Giugno 2024 M	62.619	0	0	$0
Yi Liang	CCO & President, Greater China	25 Giugno 2022 A	104.847	0	0	$0
Tao Fu	President & COO	26 Marzo 2021 M	207.000	0	0	$0
Frazor Titus Edmondson III	Chief Legal Officer	25 Giugno 2026 M	30.346	0	9	$-1.073.729
Yizhe Wang	Operating Partner	11 Maggio 2026 A	—	0	0	$0
Alan B. Sandler	Head of Global Dev., Oncology	25 Giugno 2022 A	28.985	0	0	$0
Richard Gaynor	Direttore	01 Luglio 2026 P	80.737	2	0	$65.804
Nisa Leung	Direttore	17 Giugno 2026 A	96.297	0	0	$0
Michel Vounatsos	Direttore	17 Giugno 2026 A	72.787	0	0	$0
Scott W Morrison	Direttore	17 Giugno 2026 A	56.904	0	0	$0
John D. Diekman	Direttore	17 Giugno 2026 A	122.140	0	0	$0
MOULDER LEON O JR	Direttore	17 Giugno 2026 A	94.973	0	0	$0
WIRTH PETER	Direttore	17 Giugno 2026 A	416.121	0	0	$0
Kai-Xian Chen	Direttore	31 Dicembre 2024 D	39.525	0	0	$0
William Lis	—	12 Agosto 2026 S	41.931	0	2	$-340.004

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 13 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
CANC · Tema ETF Trust	1,98%	196.972 NS	31 Maggio 2026	N-PORT
BBP · ETFis Series Trust I	1,94%	53.256 NS	30 Aprile 2026	N-PORT
SBIO · ALPS ETF Trust	1,26%	115.031 NS	31 Maggio 2026	N-PORT
FMED · Fidelity Covington Trust	0,66%	15.273 NS	31 Maggio 2026	N-PORT
PGJ · Invesco Exchange-Traded Fund Trust	0,48%	20.368 SH	08 Agosto 2026	Giornaliero
IBB · iShares Trust	0,14%	659.407 SH	08 Agosto 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,05%	1.795 SH	08 Agosto 2026	Giornaliero
BIB · ProShares Trust	0,03%	1.269 NS	31 Maggio 2026	N-PORT
DFEM · Dimensional ETF Trust	0,01%	28.261 NS	30 Aprile 2026	N-PORT
DFSE · Dimensional ETF Trust	0,01%	1.660 NS	30 Aprile 2026	N-PORT
EMCR · DBX ETF Trust	0,00%	147 NS	29 Maggio 2026	N-PORT
DFAE · Dimensional ETF Trust	0,00%	17.797 NS	30 Aprile 2026	N-PORT
DFAX · Dimensional ETF Trust	0,00%	2.911 NS	30 Aprile 2026	N-PORT

Informazioni su Zai Lab Limited - American Depositary Shares Panoramica della società da Wikipedia

ZLAB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

ZLAB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

ZLAB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 99 filer · $767.0M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 20 insider · 11 dirigenti · 10 direttori

Proprietà ETF Posseduti da 13 ETF